In this issue

Jonathan Tobin: Defending the Right to a Jewish State

Heather Hale: Compliment your kids without giving them big heads

Megan Shauri: 10 ways you are ruining your own happiness

Carolyn Bigda: 8 Best Dividend Stocks for 2015

Kiplinger's Personal Finance editors: 7 Things You Didn't Know About Paying Off Student Loans

Samantha Olson: The Crucial Mistake 55% Of Parents Are Making At Their Baby's Bedtime

Densie Well, Ph.D., R.D. Open your eyes to yellow vegetables

The Kosher Gourmet by Megan Gordon With its colorful cache of purples and oranges and reds, COLLARD GREEN SLAW is a marvelous mood booster --- not to mention just downright delish
April 18, 2014

Rabbi Yonason Goldson: Clarifying one of the greatest philosophical conundrums in theology

Caroline B. Glick: The disappearance of US will

Megan Wallgren: 10 things I've learned from my teenagers

Lizette Borreli: Green Tea Boosts Brain Power, May Help Treat Dementia

John Ericson: Trying hard to be 'positive' but never succeeding? Blame Your Brain

The Kosher Gourmet by Julie Rothman Almondy, flourless torta del re (Italian king's cake), has royal roots, is simple to make, . . . but devour it because it's simply delicious

April 14, 2014

Rabbi Dr Naftali Brawer: Passover frees us from the tyranny of time

Greg Crosby: Passing Over Religion

Eric Schulzke: First degree: How America really recovered from a murder epidemic

Georgia Lee: When love is not enough: Teaching your kids about the realities of adult relationships

Cameron Huddleston: Freebies for Your Lawn and Garden

Gordon Pape: How you can tell if your financial adviser is setting you up for potential ruin

Dana Dovey: Up to 500,000 people die each year from hepatitis C-related liver disease. New Treatment Has Over 90% Success Rate

Justin Caba: Eating Watermelon Can Help Control High Blood Pressure

The Kosher Gourmet by Joshua E. London and Lou Marmon Don't dare pass over these Pesach picks for Manischewitz!

April 11, 2014

Rabbi Hillel Goldberg: Silence is much more than golden

Caroline B. Glick: Forgetting freedom at Passover

Susan Swann: How to value a child for who he is, not just what he does

Cameron Huddleston: 7 Financial Tasks You Should Tackle Right Now

Sandra Block and Lisa Gerstner: How to Profit From Your Passion

Susan Scutti: A Simple Blood Test Might Soon Diagnose Cancer

Chris Weller: Have A Slow Metabolism? Let Science Speed It Up For You

The Kosher Gourmet by Diane Rossen Worthington Whitefish Terrine: A French take on gefilte fish

April 9, 2014

Jonathan Tobin: Why Did Kerry Lie About Israeli Blame?

Samuel G. Freedman: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Jessica Ivins: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Kim Giles: Asking for help is not weakness

Kathy Kristof and Barbara Hoch Marcus: 7 Great Growth Israeli Stocks

Matthew Mientka: How Beans, Peas, And Chickpeas Cleanse Bad Cholesterol and Lowers Risk of Heart Disease

Sabrina Bachai: 5 At-Home Treatments For Headaches

The Kosher Gourmet by Daniel Neman Have yourself a matzo ball: The secrets bubby never told you and recipes she could have never imagined

April 8, 2014

Lori Nawyn: At Your Wit's End and Back: Finding Peace

Susan B. Garland and Rachel L. Sheedy: Strategies Married Couples Can Use to Boost Benefits

David Muhlbaum: Smart Tax Deductions Non-Itemizers Can Claim

Jill Weisenberger, M.S., R.D.N., C.D.E : Before You Lose Your Mental Edge

Dana Dovey: Coffee Drinkers Rejoice! Your Cup Of Joe Can Prevent Death From Liver Disease

Chris Weller: Electric 'Thinking Cap' Puts Your Brain Power Into High Gear

The Kosher Gourmet by Marlene Parrish A gift of hazelnuts keeps giving --- for a variety of nutty recipes: Entree, side, soup, dessert

April 4, 2014

Rabbi David Gutterman: The Word for Nothing Means Everything

Charles Krauthammer: Kerry's folly, Chapter 3

Amy Peterson: A life of love: How to build lasting relationships with your children

John Ericson: Older Women: Save Your Heart, Prevent Stroke Don't Drink Diet

John Ericson: Why 50 million Americans will still have spring allergies after taking meds

Cameron Huddleston: Best and Worst Buys of April 2014

Stacy Rapacon: Great Mutual Funds for Young Investors

Sarah Boesveld: Teacher keeps promise to mail thousands of former students letters written by their past selves

The Kosher Gourmet by Sharon Thompson Anyone can make a salad, you say. But can they make a great salad? (SECRETS, TESTED TECHNIQUES + 4 RECIPES, INCLUDING DRESSINGS)

April 2, 2014

Paul Greenberg: Death and joy in the spring

Dan Barry: Should South Carolina Jews be forced to maintain this chimney built by Germans serving the Nazis?

Mayra Bitsko: Save me! An alien took over my child's personality

Frank Clayton: Get happy: 20 scientifically proven happiness activities

Susan Scutti: It's Genetic! Obesity and the 'Carb Breakdown' Gene

Lecia Bushak: Why Hand Sanitizer May Actually Harm Your Health

Stacy Rapacon: Great Funds You Can Own for $500 or Less

Cameron Huddleston: 7 Ways to Save on Home Decor

The Kosher Gourmet by Steve Petusevsky Exploring ingredients as edible-stuffed containers (TWO RECIPES + TIPS & TECHINQUES)

Jewish World Review

9 Stocks to Make You Rich

By Kathy Kristof

JewishWorldReview.com | Investors dream of owning stocks that will make them rich--companies with game-changing technology, a miracle drug or a service that will prove so popular for such a long time that it catapults the company into prominence and its stock into the stratosphere. But finding and holding on to those companies is no easy feat. Buying growth stocks is a bit like riding a bucking bronco, says Mike Lippert, manager of the Baron Opportunity fund. The ride, while rewarding, is both rocky and treacherous.

Lately, investors have lost their appetite for growth stocks, especially those with ultra-high valuation measures. The selloff gives contrarian investors more-attractive entry points. The nine stocks we feature are suitable only if you have the stomach for a lot of volatility and can handle big losses. And if you do, it's best to buy at least a few of them--if not all.

Headquarters: East Rutherford, N.J.

Share price: $12.00

52-week range: $11.90 - $17.90*

Market capitalization: $298.7 million

Annual sales: $53 million

Estimated earnings growth: Not meaningful (company losing money)

Named after the ancient trade routes that carried precious cargo between the Baltic and Mediterranean seas, Amber Road (AMBR) helps importers and exporters negotiate the cacophony of tariffs and trade restrictions that can hamper their ability to get products to market.

Operating in 125 countries, the company uses cloud-based technology to update its customers on rapidly changing rules and regulations and to ensure the ideal routing for their goods. Amber Road isn't yet profitable. But that's because the company has been grappling with the substantial upfront costs of investigating trade rules and putting the results into their system. Analyst Brendan Barnicle, of Pacific Crest Securities, says that the proceeds from Amber Road's initial public offering in March gave the company enough cash to finance the marketing and sales initiatives necessary to win new business and make better use of all that infrastructure. The demand for global trade logistics is great, he adds, so he expects rapid growth in revenues and, once the company turns profitable, in earnings as well. Analysts on average see revenues growing by 19.4% this year 17.4% in 2015.

*Publicly traded for less than one year

Headquarters: Menlo Park, Cal.

Share price: $58.02

52-week range: $22.67-$72.59

Market capitalization: $148.9 billion

Annual sales: $8.9 billion

Estimated earnings growth: 62.5% in 2014, 28.0% in 2015

After stumbling in its first year as a public company, Facebook (FB) has come back with a vengeance.

It earned $1.5 billion in 2013, and growth in the first three months of 2014 was spectacular: Earnings surged 193% from the same period a year earlier, and sales jumped 72%. One key is that advertising revenue has risen sharply thanks to a revamp that makes ads a more prominent part of Facebook news feeds. Sterne Agee analyst Arvind Bhatia thinks the company will continue to exceed analysts' estimates by boosting user engagement and using firms it has purchased or intends to acquire--such as Instagram and WhatsApp--to stimulate growth in mobile advertising. Although the stock, at 39 times estimated year-ahead earnings, looks expensive, the potential growth justifies the price.

Headquarters: Torrance, Cal.

Share price: $25.40

52-week range: $5.75-$29.29

Market capitalization: $379.6 million

Annual sales: $406.2 million

Estimated earnings growth: 261.2% in the March 2015 fiscal year, 21.9% in the March 2016 fiscal year

Unlike all the other companies on our list, Motorcar (MPAA) is a turnaround play rather than a pure growth stock.

The auto-parts maker's earnings tanked the past couple of years after the acquisition of Fenwick Automotive in 2011. Fenwick, which rebuilds old car parts, turned out to be a bust. But Motorcar Parts has split off Fenwick's assets and debts, and Fenwick is now liquidating through Chapter 7 of the federal bankruptcy code. The separation eliminated a drag on profits and allowed Motorcar to focus on its rapidly growing parts business. The increasing propensity of drivers to hang on to their cars, combined with severe winter weather, which has been tough on electrical systems and gears, has revved up sales. But because of the company's past problems, investors are underestimating its earnings potential, says Michelle Stevens, portfolio manager of the Baird SmallCap Value fund.

Headquarters: London

Share price: $25.35

52-week range: $19.48 to $60.00*

Market capitalization: 1.4 billion

Annual sales: $261.8 million

Estimated earnings growth: 25% in 2014.


Every weekday JewishWorldReview.com publishes what many in the media and Washington consider "must-reading". HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here.

Companies drilling for oil and gas in U.S. and Canadian shale formations have found a mother lode of other liquefied petroleum products, such as propane, butane and ethane. The domestic market for these fracking byproducts is glutted, but the fuels are in high demand in Europe and Asia, where they sell for two to three times the domestic price.

Navigator (NVGS) owns refrigerated shipping vessels that can transport propane and butane overseas. The company has been growing at a blistering pace, with sales soaring 62% and profits increasing 34% in 2013. Eight new ships are set to come on line in the next two years, bringing the number of ships in Navigator's fleet to 31. In addition, the company, which is registered in the Marshall Islands but has its executive offices in London, recently struck a deal to buy ships that transport ethane. The combination of surging propane, butane and ethane supplies and the tapping of the previously ignored market for ethane is likely to fuel Navigator's earnings for years to come, says Stevens.

*Publicly traded for less than one year

Headquarters: Norwalk, Conn.

Share price: $1,137.16

52-week range: $784.32 to $1,378.96

Market capitalization: $59.6 billion

Annual sales: $7.1 billion

Estimated earnings growth: 25.2% in 2014, 22.8% in 2015.

Priceline (PCLN) has already made patient, long-term investors rich, soaring from a split-adjusted $6.50 in December 2000 to its lofty four-figure price today.

But Joe Fath, manager of the T. Rowe Price Growth Stock fund, thinks the company is just getting started. The travel Web site, which competes with the likes of Orbitz and Expedia, has the most durable business model of all its competitors, Fath says. And it's in the midst of a virtuous cycle: As it signs up an increasing number of hoteliers in the U.S., Asia and Europe, it brings more customers to its sites, which include Booking.com, Rentalcars.com and Agoda, a Japanese-language site. Visitors book more reservations, which makes the sites more valuable to hoteliers, customers and stockholders. Priceline's success in the U.S. is impressive, says Fath, but rapid overseas growth is the key to further earnings gains and additional share-price appreciation.

Headquarters: Dublin, Ireland

Share price: $20.93

52-week range: $9.14 to $49.24

Market capitalization: $458.5 million

Annual sales: $32.7 million

Estimated earnings growth: Not meaningful (company losing money)

Anyone who has watched the medical drama House is likely familiar with amyloidosis--the disease no doctor wants to consider because there is no cure. Tiny Prothena (PRTA) is trying to come up with a happier ending.

Early-stage trials of the biotechnology company's NEOD001 drug found few side effects and tremendous results, says Wedbush Securities analyst Chris Marai. Although the drug has many hurdles to clear, Prothena plans to conduct more-advanced studies late this year. Because amyloidosis has no cure and Prothena's medication has been shown to be safe in early tests, Marai thinks the drug could win rapid approval from the U.S. Food and Drug Administration, opening the door to a business that could account for $1.4 billion in annual sales. In addition, the company is testing treatments for the far more common Parkinson's disease. Prothena is expected to lose money through 2017, but Marai thinks its medications are so promising and likely to become such blockbusters that long-term investors will profit mightily from the stock. (Although Prothena is registered in Ireland, its executive headquarters are in San Francisco.)

*Publicly traded for less than one year

Headquarters: Woburn, Mass

Share price: $40.75

52-week range: $20.62 to $44.17

Market capitalization: $7.7 billion

Annual sales: $1.9 billion

Estimated earnings growth: 27.7% in the September 2014 fiscal year, 13.5% in the September 2015 fiscal year

Skyworks Solutions (SWKS) makes analog semiconductors that are used in cell phones and other products that connect to the Web. But with Skyworks, you really don't care whether Apple or Samsung wins the wireless wars. Its products are in both companies' phones, not to mention in about half of all the phones sold in China, says Baird's Michelle Stevens. As more people upload photos and videos, the demand for Skyworks' amplifiers, modulators, synthesizers and switches soars, she says. Despite the company's tremendous growth potential, the stock is relatively cheap, selling for 13 times estimated year-ahead earnings.

Headquarters: Pleasanton, Cal.

Share price: $71.76

52-week range: $59.87 to $116.47

Market capitalization: $13.2 billion

Annual sales: $469 million

Estimated earnings growth: Not meaningful (company losing money)

Remember PeopleSoft, the hot human-resources software firm that was bought out by Oracle for $10 billion almost a decade ago? The same dynamic duo who launched PeopleSoft are now behind Workday (WDAY), a human-resources and financial-management company that delivers its software and services via the cloud.

Instead relying on the old model--selling products to clients who keep returning for upgrades--Workday sells its software on an as-needed basis. For clients, that turns big upfront capital outlays into more modest operating expenditures. And because the software is delivered via the cloud, it's regularly updated, providing customers a better user experience. Workday's revenues climbed 86% last year and more than doubled the year before, but the company is still in the red. Profits are likely a few years off, but Baron Opportunity fund's Lippert thinks shareholders will be richly rewarded for patience.

Headquarters: Las Vegas

Share price: $201.77

52-week range: $121.84 to $249.31

Market capitalization: $20.3 billion

Annual sales:$5.8 billion

Estimated earnings growth: $5.8 billion

U.S. investors best know Wynn Resorts (WYNN) as an operator of Las Vegas casinos run by gambling mogul Steve Wynn. But the domestic gambling recovery isn't what's driving the company's earnings, says T. Rowe Price's Joe Fath. Wynn is a long-term buy because of the properties it has developed on the Chinese island of Macau and its growing presence in the island's Cotai district. Even though Macau generates ten times more gambling revenue than Las Vegas does, the peninsula's gambling business is growing much faster than Las Vegas's. Fath thinks Wynn's Cotai properties could lead to a doubling of the company's revenues over the long term. Japan is also opening up its gaming market, and Wynn is in an ideal position to capitalize on that, he says.

Sign up for the daily JWR update. It's free. Just click here.

Interested in a private Judaic studies instructor — for free? Let us know by clicking here.

Kathy Kristof is a Contributing Editor at Kiplinger's Personal Finance.

All contents copyright 2013 The Kiplinger Washington Editors Distributed by Tribune Media Services. All rights reserved.